BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
4601 results:

  • 1. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
    Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
    J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.
    Lin J; Zhu L; Chen Y; Li Q; Ke Z; Zhang H; Huang Y; Lu J; Chen Y
    Acta Derm Venereol; 2024 May; 104():adv22146. PubMed ID: 38738772
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
    Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
    Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma.
    Wiegell SR; Hendel K; Fuchs CSK; Gehl J; Vissing M; Bro SW; Troelsen JT; Jemec GBE; Haedersdal M
    Acta Derm Venereol; 2024 May; 104():adv19678. PubMed ID: 38712969
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
    Liu Z; Yu L; Lai J; Zhang R
    Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review.
    Patel S; Armbruster H; Pardo G; Archambeau B; Kim NH; Jeter J; Wu R; Kendra K; Contreras CM; Spaccarelli N; Dulmage B; Pootrakul L; Carr DR; Verschraegen C
    PLoS One; 2024; 19(4):e0297531. PubMed ID: 38687774
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dermoscopic-Guided Shave Removal of Acquired Facial Melanocytic Nevi in Dark-skinned Individuals.
    Rezk AF; Touni AA
    Dermatol Surg; 2024 May; 50(5):434-438. PubMed ID: 38662517
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical determinants of clinical response to Sonidegib in advanced basal cell carcinoma: a monocenter experience.
    Spallone G; Carbone A; Sperati F; Frascione P; Eibenschutz L
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2923-2928. PubMed ID: 38639529
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    Chavez-Tapia NC; Sanchez-Jimenez BA; Vidaña-Perez D; Corrales-Rosas B; Balderas-Garces B; Vera-Izaguirre D; Santa Cruz FJ; Maldonado-Garcia C; Juarez-Hernandez E; Uribe M
    PLoS One; 2024; 19(4):e0290632. PubMed ID: 38626012
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
    Matthies L; Amir-Kabirian H; Gebrekidan MT; Braeuer AS; Speth US; Smeets R; Hagel C; Gosau M; Knipfer C; Friedrich RE
    PLoS One; 2024; 19(4):e0302017. PubMed ID: 38603731
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular patterns of resistance to immune checkpoint blockade in melanoma.
    Lauss M; Phung B; Borch TH; Harbst K; Kaminska K; Ebbesson A; Hedenfalk I; Yuan J; Nielsen K; Ingvar C; Carneiro A; Isaksson K; Pietras K; Svane IM; Donia M; Jönsson G
    Nat Commun; 2024 Apr; 15(1):3075. PubMed ID: 38594286
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A scoping review of vasculitis as an immune-related adverse event from checkpoint inhibitor therapy of cancer: Unraveling the complexities at the intersection of immunology and vascular pathology.
    Lee CM; Wang M; Rajkumar A; Calabrese C; Calabrese L
    Semin Arthritis Rheum; 2024 Jun; 66():152440. PubMed ID: 38579593
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.
    Schaverien MV; Singh P; Smith BD; Qiao W; Akay CL; Bloom ES; Chavez-MacGregor M; Chu CK; Clemens MW; Colen JS; Ehlers RA; Hwang RF; Joyner MM; Largo RD; Mericli AF; Mitchell MP; Shuck JW; Tamirisa N; Tripathy D; Villa MT; Woodward WA; Zacharia R; Kuerer HM; Hoffman KE
    JAMA Netw Open; 2024 Apr; 7(4):e245217. PubMed ID: 38578640
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intravascular large B-cell lymphoma of the eye: Literature review and new findings.
    Roditi E; Panicker S; Fung AT
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100053. PubMed ID: 38556129
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma.
    Kim EY; Ruiz ES; DeSimone MS; Shalhout SZ; Hanna GJ; Miller DM; Schmults C; Rettig EM; Foreman RK; Sethi R; Thakuria M; Silk AW
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):414-420. PubMed ID: 38546619
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal skin Electron Therapy.
    Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
    Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
    Stavi V; Khaire N; Lipton JH; Kumar R
    Curr Oncol; 2024 Feb; 31(3):1246-1252. PubMed ID: 38534926
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
    Yokota K; Takenouchi T; Fujisawa Y; Fukushima S; Uchi H; Inozume T; Kiyohara Y; Uhara H; Nakagawa K; Furukawa H; Han S; Watanabe M; Noguchi K; Yamazaki N
    J Dermatol; 2024 May; 51(5):632-642. PubMed ID: 38529706
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
    Stark L; Kasajima A; Stögbauer F; Schmidl B; Rinecker J; Holzmann K; Färber S; Pfarr N; Steiger K; Wollenberg B; Ruland J; Winter C; Wirth M
    Clin Epigenetics; 2024 Mar; 16(1):47. PubMed ID: 38528631
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 231.